a public good project by the
Synthesis
Company
of California

© 2026

Adrenocortical carcinoma: a clinician's update | doi.page

0 citations0 references

Google Scholar doi.org

Adrenocortical carcinoma: a clinician's update

Nature Reviews Endocrinology·2011·Vol. 7(6), pp. 323–335

Citations Over TimeTop 1% of 2011 papers

Martin Faßnacht, Rossella Libé, Matthias Kroiß, Bruno Allolio

Related Papers

→ Adjunctive treatment of adrenocortical carcinoma(2008)58 cited
→ Practical treatment using mitotane for adrenocortical carcinoma(2014)39 cited
→ High-Dose Mitotane-Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma(2017)9 cited
→ Is There a Role for Low Doses of Mitotane (o,p'-DDD) as Adjuvant Therapy in Adrenocortical Carcinoma?(1998)41 cited
→ Consensus on the Treatment of Adrenocortical Carcinoma with Mitotane(2021)(2021)